Tubigon, Jesse .

HRN: 25-94-93  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/02/2024
10/08/2024
IV
4.5 G LOADING DOSE THEN 2.25 G
Q8
CELLLULITIS, LEFT L EG
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: